This Study in Patients With Chronic Lymphocytic Leukaemia is Done to Determine a Safe and Effective Dose of BI 836826 in Combination With Venetoclax
Clinical trial NCT03343678 · WITHDRAWN
Trial details
- NCT number
- NCT03343678
- Sponsor
- Boehringer Ingelheim
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-17
- Primary completion
- 2018-05-25
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.